Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci

Molecular Psychiatry

Volumn 8, Issue 3, 2003, Pages 299-308

  Hawi, Z ^a   Lowe, N ^a   Kirley, A ^a   Gruenhage, F ^b   Nothen M ^c   Greenwood, T ^d   Kelsoe, J ^d   Fitzgerald, M ^a   Gill, M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Attention deficit hyperactivity disorder; DAT1; DBH and DRD5; Haplotype based haplotype relative risk; Linkage disequilibrium

Indexed keywords

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA FLANKING REGION; EXON; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMORPHIC LOCUS; PRIORITY JOURNAL;

ADOLESCENT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; DOPAMINE BETA-HYDROXYLASE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; RISK FACTORS;

EID: 0037499734     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001290     Document Type: Article

References (28)

1. Tannock R. Attention deficit hyperactivity disorder: advances in cognitive, neurobiological and genetic research. J Child Psychol Psychiatry 1998; 39: 65-99.
2. Cook Jr EH, Stein MA, Krasowski MD, Cox NI, Olkon DM, Kieffer JE et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993-998.
3. LaHoste GL, Swanson JM, Wigal SB, Glabe C, Wigal T, King N et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1: 121-124.
4. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T et al. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 1998; 3: 38-41.
5. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997; 2: 311-313.
6. Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999; 4: 192-196.
7. Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson P. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry 2000; 5: 396-404.
8. Barr CL, Wigg KG, Feng Y, Zai G, Malone M, Roberts W et al. Attention-deficit hyperactivity disorder and the gene for the dopamine D5 receptor. Mol Psychiatry 2000; 5: 548-551.
9. Payton A, Holmes J, Barrett JH, Hever T, Fitzpatrick H, Trumper AL et al. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am J Med Genet (Neuropsych Genet) 2001; 105: 464-470.
10. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet (Neuropsych Genet) 2002; 114: 154-158.
11. Risch NJ. Searching for genetics determinants in the new millennium. Nature 2000; 405: 847-856.
12. Zhao Z, Jin L, Fu YX, Ramsay M, Jenkins T, Leskinen E et al. Worldwide DNA sequence variation in a 10-kilobase noncoding region on human chromosome 22. Proc Natl Acad Sci USA 2000; 97: 11354-11158.
13. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001; 2: 91-99.
14. Clark AG, Weiss KM, Nickerson DA, Taylor SL, Buchanan A, Stengard J et al. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet 1998; 63: 595-612.
15. Kendler K, MacLean CJ, Ma Y, O'Neill FA, Walsh D, Straub RE et al. Marker to marker linkage disequilibrium on chromosomes 5q, 6p and 8p in Irish Pedigrees. Am J Med Genet (Neuropsych Genet) 1998; 88: 29-33.
16. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 1999; 22: 139-144.
17. Hawi Z, Daly G, Fitzgerald M, Gill M. No association of the dopamine DRD4 receptor gene polymorphisms with the attention deficit hyperactivity disorder (ADHD) in the Irish Population. Am J Med Genet (Neuropsych Genet) 2000; 96: 268-272.
18. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 885-890.
19. Grünhage F, Schulze TG, Müller DJ, Lanczik M, Franzek E, Albus M et al. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). Mol Psychiatry 2000; 5: 275-282.
20. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA et al. Segmental linkage disequilibrium within the dopamine transporter gene. Mol Psychiatry 2002; 7:165-173.
21. Huttley GA, Smith MW, Carrington M, O'Brien SJ. A scan for linkage disequilibrium across the human genome. Genetics 1999; 152: 1711-1722.
22. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001; 29: 229-232.
23. Goldstein D. Islands of linkage disequilibrium. Nat Genet 2001; 29: 109-111.
24. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000; 22: 133-139.
25. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-237.
26. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29: 223-228.
27. Wei J, Ramchand CN, Hemmings GP. Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet 1997; 99: 52-55.
28. Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH et al. Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 1998; 102: 533-540.